Publicacións nas que colabora con María de la Fuente Freire (22)

2021

  1. Carboxymethyl-β-glucan/chitosan nanoparticles: new thermostable and efficient carriers for antigen delivery

    Drug Delivery and Translational Research, Vol. 11, Núm. 4, pp. 1689-1702

  2. Sphingomyelin nanosystems loaded with uroguanylin and etoposide for treating metastatic colorectal cancer

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Biofabrication of 3D tumor models in cancer research

    Biomaterials for 3D Tumor Modeling (Elsevier), pp. 67-90

2019

  1. A multifunctional drug nanocarrier for efficient anticancer therapy

    Journal of Controlled Release, Vol. 294, pp. 154-164

  2. Self-assembled hyaluronan nanocapsules for the intracellular delivery of anticancer drugs

    Scientific Reports, Vol. 9, Núm. 1

  3. Versatile protamine nanocapsules to restore miR-145 levels and interfere tumor growth in colorectal cancer cells

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 142, pp. 449-459

2016

  1. A comparative study of curcumin-loaded lipid-based nanocarriers in the treatment of inflammatory bowel disease

    Colloids and Surfaces B: Biointerfaces, Vol. 143, pp. 327-335

  2. Polymeric nanocapsules: a potential new therapy for corneal wound healing

    Drug Delivery and Translational Research, Vol. 6, Núm. 6, pp. 708-721

  3. Selective interaction of PEGylated polyglutamic acid nanocapsules with cancer cells in a 3D model of a metastatic lymph node

    Journal of Nanobiotechnology, Vol. 14, Núm. 1

2015

  1. Controlled release microspheres loaded with BMP7 suppress primary tumors from human glioblastoma

    Oncotarget, Vol. 6, Núm. 13, pp. 10950-10963

  2. Nanoengineering of vaccines using natural polysaccharides

    Biotechnology Advances, Vol. 33, Núm. 6, pp. 1279-1293

  3. Nanotherapies for the treatment of ocular diseases

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 95, pp. 279-293

2014

  1. Implantable controlled release devices for BMP-7 delivery and suppression of glioblastoma initiating cells

    Biomaterials, Vol. 35, Núm. 9, pp. 2859-2867

  2. Nanotechnology approaches for cancer immunotherapy and immunomodulation

    Nano-oncologicals: new targeting and delivery approaches (Springer Suiza), pp. 215-224

2012

  1. Exploring the efficiency of gallic acid-based dendrimers and their block copolymers with PEG as gene carriers

    Nanomedicine, Vol. 7, Núm. 11, pp. 1667-1681

  2. Nanovaccines: Nanocarriers for antigen delivery

    Biologie Aujourd'hui, Vol. 206, Núm. 4, pp. 249-261

2011

  1. Intracellular trafficking of hyaluronic acid-chitosan oligomerbased nanoparticles in cultured human ocular surface cells

    Molecular Vision, Vol. 17, pp. 279-290

2010

  1. Chitosan-based nanostructures: A delivery platform for ocular therapeutics

    Advanced Drug Delivery Reviews, Vol. 62, Núm. 1, pp. 100-117

  2. Core-shell dendriplexes with sterically induced stoichiometry for gene delivery

    Macromolecules, Vol. 43, Núm. 17, pp. 6953-6961

  3. Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles

    Cornea, Vol. 29, Núm. 5, pp. 550-558